CN Patent

CN114306347A — 用于治疗性激素依赖性疾病的双重nk-1/nk-3受体拮抗剂

Assigned to Kangdi Medical Co ltd · Expires 2022-04-12 · 4y expired

What this patent protects

本发明涉及双重NK‑1/NK‑3受体拮抗剂或其药学上可接受的盐在治疗性激素依赖性疾病中的新用途。

USPTO Abstract

本发明涉及双重NK‑1/NK‑3受体拮抗剂或其药学上可接受的盐在治疗性激素依赖性疾病中的新用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN114306347A
Jurisdiction
CN
Classification
—
Expires
2022-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Kangdi Medical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.